Perelman School of Medicine at the University of Pennsylvania

Penn Medicine Partners with Local Restaurants to Create Healthcare Meal Delivery Platform

Nourished supports local restaurants and frontline healthcare staff during COVID-19 pandemic

Newswise — Philadelphia—Penn Medicine is proud to announce the creation and launch of Nourished, a new meal delivery platform for frontline hospital staff, to ensure safe and convenient access to local takeout meals during the COVID-19 pandemic. Nourished allows staff to easily order affordable meals from a curated list of local restaurants via text message.

Penn Medicine’s Workforce Wellness Committee partnered with the Penn Medicine Center for Health Care Innovation to create the program. Nourished launched as a pilot at Penn Presbyterian Medical Center (PPMC) on April 1, 2020 and will be available at Penn Medicine’s other downtown hospitals—the Hospital of the University of Pennsylvania and Pennsylvania Hospital—on April 22, 2020. Five restaurants are currently participating in the program: Baology, Cafe Ynez, El Merkury, On Point Bistro, and Pumpkin.

Ryan Schumacher, an innovation associate at the Penn Medicine Center for Health Care Innovation, initially proposed Nourished. Lisa Bellini, MD, chair of the Workforce Wellness Committee and senior vice dean of Academic Affairs in the Perelman School of Medicine at the University of Pennsylvania, saw its potential, and in less than two weeks from inception the program was up and running at PPMC with the support of founding restaurant partners Judy Ni at Baology and Jill Weber of Café Ynez. Ni and Weber partnered early in the initiative, co-designing the program with Penn to meet the needs of restaurants and the health system.

“Many aspects of daily life have changed with the arrival of the coronavirus, including ordering take-out. Food access during the pandemic has been a challenge, both for staff looking for a safe and affordable meal and for restaurants who have been hurt by a lack of business,” said Bellini. “We knew this was something we could help solve for, and a team quickly came together—from innovation experts to medical students like lead backend developer Chris Streiffer—to create Nourished.”

Nourished ensures safe practices are consistently followed when meals are prepared and delivered through participating agreements with each restaurant. Meals are packaged individually so that contact between each meal for staff is minimized. Additionally, contactless delivery prevents the possible spread of the virus and ensures that all meals are transported directly from the restaurant’s kitchen to a controlled hospital access point, respecting physical distancing. Since its launch, Penn staff have ordered more than 750 meals through the program.

Nourished also allows staff to help restaurants in the community that are in need of support during the pandemic. Staff can order lunch or dinner from a menu of three to four options from the restaurant partners. The orders help local restaurants stay open and continue their operations during what has become a challenging time for the Philadelphia food scene.

“Nourished helps restaurants in the community out while providing meals in a safe, sustainable, and delightful way to all of our hard-working health care professionals—it’s a true win-win,” said Schumacher, the Nourished program lead. “Our goal is to ensure employees can rely on Nourished to provide delicious food and our local community restaurants can rely on us for support. It’s been incredible to see the way the community has rallied around this.”

Schumacher and Bellini hope that Nourished can scale not only within Penn Medicine but to other health systems and communities interested in creating their own programs, with the continued development of protocols and a web platform for Nourished.

To join Nourished or for more information, Penn Medicine staff at Penn Presbyterian Medical Center can visit the PennMedicineTogether website.

###

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $8.6 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $494 million awarded in the 2019 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is powered by a talented and dedicated workforce of more than 43,900 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2019, Penn Medicine provided more than $583 million to benefit our community.

 




Filters close

Showing results

110 of 5584
Released: 7-May-2021 1:40 PM EDT
There is no evidence that vaccines could cause harm to people who have recovered from COVID-19
Newswise

An article published by Robert F. Kennedy Jr.’s anti-vaccination organization and widely shared on social media questions the need of vaccinating those who’ve already recovered from COVID-19. The article says there’s a "potential risk of harm, including death" in getting the vaccines. We report this claim as false. There is no evidence that vaccinating people who had previously had COVID is resulting in an increased risk of adverse events.

Newswise: Abbott.jpg
Released: 7-May-2021 1:00 PM EDT
FSU expert available to discuss intellectual property and COVID-19 vaccines
Florida State University

By: Bill Wellock | Published: May 7, 2021 | 11:55 am | SHARE: President Joe Biden has expressed his support for a World Trade Organization proposal to waive intellectual property rights for COVID-19 vaccines.Florida State University law professor Frederick Abbott, the Edward Ball Eminent Scholar Professor of International Law, is available to comment on international intellectual property rights and global economic issues around the proposal.

access_time Embargo lifts in 2 days
Embargo will expire: 11-May-2021 11:00 AM EDT Released to reporters: 7-May-2021 1:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-May-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 7-May-2021 11:15 AM EDT
Asthma attacks plummeted among Black and hispanic/latinx individuals during the COVID-19 pandemic
Brigham and Women’s Hospital

Asthma attacks account for almost 50 percent of the cost of asthma care which totals $80 billion each year in the United States

access_time Embargo lifts in 2 days
Embargo will expire: 11-May-2021 11:00 AM EDT Released to reporters: 7-May-2021 10:40 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-May-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 7-May-2021 9:00 AM EDT
Navigating the COVID-19 crisis to prevent pressure injuries: Learning health system helped one hospital adapt and update care in real time
Wolters Kluwer Health: Lippincott

Early in the COVID-19 pandemic, healthcare systems scrambled to modify patient care processes – particularly when it came to strategies aimed at reducing the risk of hospital-related complications. A look at how one hospital applied its learning health system (LHS) framework to respond to a COVID-19-related increase in hospital-acquired pressure injuries (HAPIs) is presented in the May/June Journal for Healthcare Quality (JHQ), the peer-reviewed journal of the National Association for Healthcare Quality (NAHQ). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Ultra-Fast COVID-19 Sensor Invented at Texas Tech Gets Boost Into International Markets
Released: 7-May-2021 8:55 AM EDT
Ultra-Fast COVID-19 Sensor Invented at Texas Tech Gets Boost Into International Markets
Texas Tech University

EviroTech LLC announced today (May 7) a $4 million investment into the company by 1701 Ventures GmbH of Göttingen, Germany, which will allow EviroTech to complete the final design, production startup and market introduction of its Ultra-Fast COVID-19 detection sensor.

Released: 7-May-2021 7:05 AM EDT
Rutgers Recruiting Participants for Pfizer COVID-19 Pediatric Vaccine Clinical Trial
Rutgers University-New Brunswick

Rutgers has been selected as a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children ages 6 months to 11 years. This is the third time Rutgers has served as a COVID-19 vaccine clinical trial site for pharmaceutical companies. Last fall, it conducted trials for Moderna and Johnson & Johnson.


Showing results

110 of 5584

close
1.10227